BUY Zydus Lifesciences — Ashish Kyal, 24 Sept 2026

byAshish Kyal, Waves Strategy AdvisorsHorizon: NA (inferred Swing (≤2wk))24 Sept 2026via ET Now (Live)

Entry₹1,175Inferred

Target₹1,220

Stop loss₹1,140-2.98% risk

CMP₹1,203.912h ago

Active+2.46%+1.34%upside left 12d left

Follow Ashish Kyal for new calls(24% target hit, 140 closed calls)Get alerts Watch ZYDUSLIFE for new buy/sell callsGet alerts See 3 other Swing calls on ZYDUSLIFE See 310 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 26 Sept, 4:50 am IST

4 supporting1 neutral1 opposing

Supports the BUY call (4)

MACD above its signal line — bullish momentum

Technicals · macd·25 Sept · today

3 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·25 Sept · today

Bernstein bets on this drugmaker for 28% upside citing a key value driver for the future

NewsCnbc-Tv18·18 Sept · 1w ago

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·12 Aug · 1mo ago

Neutral / worth noting (1)

Zydus Lifesciences (NSE:ZYDUSLIFE): Why Did It Publish a Lost Share Certificate Notice?

NewsGoogle News·24 Sept · yesterday

Weighs against the BUY call (1)

RSI at 71 — overbought territory

Technicals · rsi·25 Sept · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

BUY Zydus Lifesciences Limited — Ashish Kyal, Waves Strategy Advisors

AI Assessment